CAUSES AND IMPACT OF PREMATURE INTERRUPTION OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACTIVE CANCER

Marissa Lombardo,Polydoros Kampaktsis,Attila Feher,Simon Mantha,Usman Baber,Richard Steingart,Dipti Gupta

CAUSES AND IMPACT OF PREMATURE INTERRUPTION OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACTIVE CANCER

2018

Marissa Lombardo
Polydoros Kampaktsis
Attila Feher
Simon Mantha
Usman Baber
Richard Steingart
Dipti Gupta

Premature dual antiplatelet therapy interruption (DAPTi) is a challenging problem in patients with hematologic malignancies after percutaneous coronary intervention (PCI). The epidemiology and impact of DAPTi in these patients is not known. 64 patients with active hematologic malignancy at Memorial

Keywords:

Cancer
Internal medicine
Diabetes mellitus
Cardiology
Medicine
Percutaneous coronary intervention
Epidemiology
Hematologic malignancy
in patient
Conventional PCI

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations